Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.01 | -26.35 |
| PEG Ratio (TTM) | 0.01 | -7.63 |
| P/S Ratio (TTM) | 0.04 | 45.57 |
| P/B Ratio (TTM) | 0.02 | 32.07 |
| P/FCF Ratio (TTM) | -0.01 | -9.72 |
| Price to 5YR AVG Earnings Ratio | N/A | -7.44 |
| Price to 5YR AVG FCF Ratio | N/A | -15.00 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -74.14% | -17.05% |
| ROE (TTM) | -87.75% | 24.45% |
| Net Profit Margin (TTM) | -369.98% | -526.66% |
| ROIC 5YR AVG | N/A | -6.69% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -3.38% | -125.05% | N/A |
| Revenue | 20.99% | 30.08% | N/A |
| Net Income | -4.17% | -53.32% | N/A |
| Cash Flow | 37.95% | -125.98% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.12 | 5.80 |
| Quick Ratio (TTM) | 3.12 | 5.58 |
| D/E Ratio (TTM) | 0.12 | 1.15 |
| Interest Coverage (TTM) | N/A | -8.06 |
| Piotroski F-Score | 2 | 4 |
| Altman Z-Score | N/A | 13.36 |
| LTL to 5YR AVG FCF | N/A | 0.04 |
| Shares Outstanding Growth 5YR AVG | N/A | 39.93% |